| Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00387504) | California Cancer Consortium | 2006-11-01 |
| Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00550927) | Eli Lilly and Company | 2006-11-01 |
| Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors (NCT00423865) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors (NCT00645060) | City of Hope Medical Center | 2006-10-09 |
| Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer (NCT00544063) | Institut du Cancer de Montpellier - Val d'Aurelle | 2006-10-01 |
| Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer (NCT00362986) | Alliance for Clinical Trials in Oncology | 2006-10-01 |
| S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00352443) | SWOG Cancer Research Network | 2006-09-01 |
| Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT00483366) | University of Nebraska | 2006-08-15 |
| Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer (NCT00408499) | University of California, Davis | 2006-08-01 |
| Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00320073) | UNC Lineberger Comprehensive Cancer Center | 2006-08-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors (NCT00307255) | UNC Lineberger Comprehensive Cancer Center | 2006-08-01 |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors (NCT00372736) | NCIC Clinical Trials Group | 2006-07-27 |
| Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer (NCT00498992) | Ingalls Memorial Hospital | 2006-07-01 |
| AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00348699) | National Cancer Institute (NCI) | 2006-07-01 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00536601) | Roswell Park Cancer Institute | 2006-06-29 |
| Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer (NCT00296036) | Alliance for Clinical Trials in Oncology | 2006-06-01 |
| ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00387608) | National Institutes of Health Clinical Center (CC) | 2006-06-01 |
| APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer (NCT00343460) | Heron Therapeutics | 2006-06-01 |
| 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00293345) | National Cancer Institute (NCI) | 2006-06-01 |
| AFP464 in Treating Patients With Advanced Solid Tumors (NCT00369200) | National Cancer Institute (NCI) | 2006-06-01 |
| PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma (NCT00354185) | National Cancer Institute (NCI) | 2006-05-01 |
| TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors (NCT00356980) | National Institutes of Health Clinical Center (CC) | 2006-05-01 |
| Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer (NCT00899808) | Rutgers, The State University of New Jersey | 2006-05-01 |
| An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index (NCT00128570) | Virginia Polytechnic Institute and State University | 2006-04-01 |
| Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors (NCT00324480) | National Cancer Institute (NCI) | 2006-03-01 |
| PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00348985) | National Cancer Institute (NCI) | 2006-03-01 |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer (NCT00296062) | Case Comprehensive Cancer Center | 2006-03-01 |
| Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors (NCT00331955) | National Cancer Institute (NCI) | 2006-03-01 |
| Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer (NCT00313573) | Indiana University | 2006-02-01 |
| Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00112684) | National Cancer Institute (NCI) | 2006-02-01 |
| Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia (NCT00275080) | National Cancer Institute (NCI) | 2006-02-01 |
| Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer (NCT00514215) | Barbara Ann Karmanos Cancer Institute | 2006-01-01 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer (NCT00661999) | Mayo Clinic | 2006-01-01 |
| Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men (NCT00287833) | National Cancer Institute (NCI) | 2006-01-01 |
| Spinal Cord Compression. ICORG 05-03, V6 (NCT00968643) | Cancer Trials Ireland | 2006-01-01 |
| Levocarnitine in Treating Fatigue in Cancer Patients (NCT00091169) | ECOG-ACRIN Cancer Research Group | 2005-12-16 |
| Sorafenib and Bortezomib in Treating Patients With Advanced Cancer (NCT00303797) | National Cancer Institute (NCI) | 2005-12-01 |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors (NCT00389922) | University of California, Davis | 2005-12-01 |
| PR-104 in Treating Patients With Advanced Solid Tumors (NCT00349167) | Proacta, Incorporated | 2005-12-01 |
| Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function (NCT00275093) | National Cancer Institute (NCI) | 2005-12-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors (NCT00559195) | Centre Hospital Regional Universitaire de Limoges | 2005-11-01 |
| Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00243100) | National Cancer Institute (NCI) | 2005-11-01 |
| Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors (NCT00305799) | Case Comprehensive Cancer Center | 2005-11-01 |
| AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma (NCT00562380) | Amgen | 2005-10-01 |
| Octreotide in Treating Patients With Cancer-Related Malignant Ascites (NCT00182754) | Alliance for Clinical Trials in Oncology | 2005-10-01 |
| American Ginseng in Treating Patients With Cancer-Related Fatigue (NCT00182780) | Alliance for Clinical Trials in Oncology | 2005-10-01 |
| 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery (NCT00248521) | Institute of Cancer Research, United Kingdom | 2005-10-01 |
| AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00324597) | Jonsson Comprehensive Cancer Center | 2005-10-01 |
| Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking (NCT00301145) | SRI International | 2005-10-01 |
| Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00126620) | University Health Network, Toronto | 2005-09-01 |
| Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00128622) | H. Kim Lyerly | 2005-09-01 |
| Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00255658) | National Cancer Institute (NCI) | 2005-09-01 |
| Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00121277) | University Health Network, Toronto | 2005-09-01 |
| Tissue Sample Collection From Patients With Fanconi Anemia (NCT00899522) | OHSU Knight Cancer Institute | 2005-08-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00255749) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors (NCT00433407) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations (NCT00169312) | Josephine Ford Cancer Center | 2005-08-01 |
| Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer (NCT00274859) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2005-08-01 |
| Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers (NCT00255697) | Case Comprehensive Cancer Center | 2005-07-01 |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (NCT00138177) | National Cancer Institute (NCI) | 2005-07-01 |
| Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy (NCT00296049) | Wake Forest University Health Sciences | 2005-07-01 |
| Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00227513) | National Cancer Institute (NCI) | 2005-07-01 |
| AEG35156 and Docetaxel in Treating Patients With Solid Tumors (NCT00357747) | NCIC Clinical Trials Group | 2005-06-09 |
| Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00253344) | Case Comprehensive Cancer Center | 2005-06-01 |
| PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases (NCT00382252) | Institut Bergonié | 2005-05-02 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00119236) | National Cancer Institute (NCI) | 2005-05-01 |
| Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking (NCT00245076) | National Cancer Institute (NCI) | 2005-04-01 |
| Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma (NCT00124605) | National Cancer Institute (NCI) | 2005-04-01 |
| Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00387322) | University of California, Davis | 2005-03-01 |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors (NCT00389805) | University of California, Davis | 2005-03-01 |
| Study of Hair Samples From Patients With Cancer (NCT00899691) | National Institutes of Health Clinical Center (CC) | 2005-03-01 |
| Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet (NCT00217490) | Kaiser Permanente | 2005-03-01 |
| Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors (NCT00290680) | Medical University of South Carolina | 2005-03-01 |
| Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer (NCT00281853) | Case Comprehensive Cancer Center | 2005-03-01 |
| Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors (NCT00276575) | Herbert Hurwitz, MD | 2005-03-01 |
| Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors (NCT00263861) | Case Comprehensive Cancer Center | 2005-03-01 |
| AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) (NCT00107250) | NCIC Clinical Trials Group | 2005-01-21 |
| Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment (NCT00544284) | City of Hope Medical Center | 2005-01-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors (NCT00303732) | Daniel George, MD | 2004-12-01 |
| Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer (NCT00091247) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00368914) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-12-01 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00520000) | UNC Lineberger Comprehensive Cancer Center | 2004-12-01 |
| Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00376727) | University of California, Davis | 2004-12-01 |
| 11C Topotecan PET Imaging (NCT00253461) | Case Comprehensive Cancer Center | 2004-12-01 |
| Creatine in Treating Patients With Cancer-Associated Weight Loss (NCT00081250) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors (NCT00388089) | University of California, Davis | 2004-12-01 |
| Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers (NCT00095862) | Wiseman Research Initiatives LLC | 2004-11-01 |
| SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma (NCT00101244) | National Cancer Institute (NCI) | 2004-11-01 |
| Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00096005) | National Cancer Institute (NCI) | 2004-11-01 |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00238225) | Roswell Park Cancer Institute | 2004-11-01 |
| SJG-136 in Treating Patients With Advanced Solid Tumors (NCT00103220) | National Cancer Institute (NCI) | 2004-11-01 |
| Indole-3-Carbinol in Preventing Cancer in Healthy Participants (NCT00100958) | University of Kansas | 2004-11-01 |
| Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery (NCT00096590) | National Cancer Institute (NCI) | 2004-11-01 |
| Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants (NCT00091325) | University of Arizona | 2004-10-01 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer (NCT00486356) | University of Nebraska | 2004-10-01 |
| Health Education in Improving the Understanding of Medical Information (NCT00387998) | Dartmouth-Hitchcock Medical Center | 2004-10-01 |
| CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors (NCT00098501) | National Cancer Institute (NCI) | 2004-10-01 |